HOXD13 and Ewing sarcoma: Thus, these data together show that continued high level expression of both MLL1 and HOXD13 are required for maintenance of the oncogenic phenotype of Ewing sarcoma and that HOXD13 overexpression is associated with H3K4me3 and MLL1 binding at its promoter.